Bank of New York Mellon Corp - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$45,181,000
+79.9%
975,210
-5.3%
0.01%
+71.4%
Q1 2019$25,113,000
+79.9%
1,030,103
+5.2%
0.01%
+75.0%
Q4 2018$13,958,000
-11.0%
979,542
-5.1%
0.00%0.0%
Q3 2018$15,689,000
-9.6%
1,032,129
-0.1%
0.00%
-20.0%
Q2 2018$17,346,000
-3.3%
1,033,661
-6.0%
0.01%0.0%
Q1 2018$17,941,000
+39.0%
1,099,367
+9.0%
0.01%
+66.7%
Q4 2017$12,905,000
+7.7%
1,008,216
+3.5%
0.00%0.0%
Q3 2017$11,984,000
+75.5%
974,345
+19.4%
0.00%
+50.0%
Q2 2017$6,829,000
-9.3%
815,870
-3.1%
0.00%0.0%
Q1 2017$7,528,000
+6.5%
842,076
+4.7%
0.00%0.0%
Q4 2016$7,068,000
+79.5%
804,102
+37.8%
0.00%
+100.0%
Q3 2016$3,938,000
+70.8%
583,377
-9.9%
0.00%0.0%
Q2 2016$2,305,000
+20.7%
647,567
+0.1%
0.00%0.0%
Q1 2016$1,909,000
-27.7%
646,882
+3.4%
0.00%0.0%
Q4 2015$2,641,000
-11.3%
625,866
-4.1%
0.00%0.0%
Q3 2015$2,976,000
-47.4%
652,685
-16.9%
0.00%
-50.0%
Q2 2015$5,662,000
-0.7%
785,315
+1.5%
0.00%
+100.0%
Q1 2015$5,704,000
+74.1%
773,952
+11.7%
0.00%0.0%
Q4 2014$3,276,000
+33.4%
692,641
+0.7%
0.00%0.0%
Q3 2014$2,456,000
-58.0%
688,097
-46.3%
0.00%0.0%
Q2 2014$5,848,000
+90.7%
1,282,286
+96.5%
0.00%0.0%
Q1 2014$3,067,000
-0.8%
652,581
+5.8%
0.00%0.0%
Q4 2013$3,091,000
-59.3%
616,904
-49.5%
0.00%0.0%
Q3 2013$7,594,000
+183.6%
1,220,850
+107.0%
0.00%0.0%
Q2 2013$2,678,000589,7840.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
MUFG Americas Holdings Corp 36,200$71,0000.00%
View complete list of ARRAY BIOPHARMA INC shareholders